Measuring Adherence With Claims Data For Schizophrenic Patients
Medication non-adherence is commonly associated with adverse health conditions and increased economic burden to the health care system and is a critical issue especially in case of chronic therapies such as schizophrenia. Due to its usefulness in recent years, administrative claims data has been one of the most commonly used sources for calculating medication adherence.
Source: www.medicalnewstoday.com

A Genetic Link To Premature Ejaculation
Premature ejaculation can be embarrassing, but a new study suggests that it might be a genetic disorder. Researchers from Turku, Finland, interviewed more than three thousand men - all pairs of male twins and their older or younger brothers - about the first time they had sex. Many participants in the study reported that they had suffered from erectile dysfunction and premature ejaculation at their first sexual encounter.
Source: www.medicalnewstoday.com

New Analyses Show Nasonex Is More Effective Than Loratadine For The Treatment Of Nasal Allergy Symptoms And At Least Comparable For Ocular Symptoms
According to new data presented today for the first time, patients with seasonal allergic rhinitis (SAR) experienced greater relief of nasal symptoms and equivalent relief of ocular symptoms with NASONEX® (mometasone furoate monohydrate) Nasal Spray, 50 mcg* versus the antihistamine loratadine. Results were presented at the Congress of the European Academy of Allergology and Clinical [...]
Source: feedproxy.google.com

A Satisfying Sex Life Eludes Around Two In Three Men
Pfizer's inaugural Asia Pacific Sexual Health and Overall Wellness (AP SHOW) survey has uncovered staggering levels of sexual dissatisfaction, with 60% of men and around 60% of women in Australia saying they are not very satisfied with their sex lives. Erectile Dysfunction (ED) continues to be a key cause of dissatisfaction.
Source: www.medicalnewstoday.com

Cherry-Flavoured Malaria Drug Launched For Children In Africa - UK's Department For International Development Funds Innovative Anti-Malaria Research
A new child-friendly malaria drug which will be distributed in Africa, where a child dies every 30 seconds from malaria, is to be launched in the UK on Monday 23 March 2009. The new drug is the result of public-private collaboration between Medicines for Malaria Venture (MMV), a non-profit funded by the UK's Department for International Development, and the drug company Novartis.
Source: www.medicalnewstoday.com

Why take cholesterol-lowering drugs when cholesterol is not high?
DEAR DR. DONOHUE: My doctor wants me to take a statin drug even though my total cholesterol is normal and my LDL cholesterol isn’t very high. The only other abnormal test was the CRP test. He says that a statin for someone like me has been shown to prevent heart attacks. My father died of [...]
Source: feedproxy.google.com

Potential For Delivering Antibiotic Treatment Via Aerosol
Aerosol delivery of antibiotics via nanoparticles may provide a means to improve drug delivery and increase patient compliance, thus reducing the severity of individual illnesses, the spread of epidemics, and possibly even retarding antibiotic resistance. Delivery of antibiotics via nanoparticles has shown promise as a drug delivery mechanism, particularly for controlled release or depot delivery of drugs to decrease the number of doses required to achieve a clinical effect.
Source: www.medicalnewstoday.com

VIVUS Initiates Open Label Safety Study Of Avanafil For Erectile Dysfunction
VIVUS, Inc. (Nasdaq: VVUS), a biopharmaceutical company developing innovative, next-generation therapies to address unmet needs in obesity, diabetes and sexual health, announced that it has initiated an open label safety study (TA-314) with its investigational drug, avanafil, in males with erectile dysfunction (ED).
Source: www.medicalnewstoday.com

Male Sexual Function Comes Back Faster With New Surgical Procedure Developed At CINJ
A new robotic surgical technique developed at The Cancer Institute of New Jersey (CINJ) for the removal of all or part of the prostate gland is showing what investigators call a "dramatic improvement" in a male's sexual potency rate. The results were recently presented at the 26th World Congress Endourology meeting in Shanghai, China. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School and has also developed a Center of Excellence for robotic surgery.
Source: www.medicalnewstoday.com